Dexcom– tag –
-
Dexcom Selected as First Participant in FDA’s TEMPO Pilot Program to Advance AI-Powered Glucose Health for Early Prediabetes & T2D Intervention
Business Wire (via Dexcom Investor Relations) USA Overview Dexcom has been selected as the inaugural participant in the FDA's TEMPO (Technology-Enabled Meaningful Patient Outcomes) digital health devices pilot program, aiming to accelera... -
FDA Selects Dexcom as First Participant in ‘TEMPO’ Digital Health Pilot Program
MedTech Dive USA Overview The FDA has selected Dexcom as the first participant in its new Technology-Enabled Meaningful Patient Outcomes (TEMPO) Pilot Program. This pilot will enable Dexcom to implement an AI-enabled glucose health progr... -
RT-CGM Reduces Inpatient and Emergency Department Encounters, Cutting Healthcare Costs for Non-Insulin-Treated Type 2 Diabetes Patients
PubMed USA Overview A retrospective study using US administrative claims data reveals that real-time continuous glucose monitoring (RT-CGM) significantly reduces healthcare resource utilization and associated medical costs among non-insu... -
diaTribe.org Recommends 6 Wearable Devices for Diabetes Management, Featuring Apple Watch & Samsung Galaxy Watch Integration
diaTribe.org USA Overview diaTribe.org has highlighted six wearable devices, including Apple Watch, Samsung Galaxy Watch, Google Pixel Watch, and Garmin Watch, that enhance diabetes management. These devices integrate with CGM systems li... -
Dexcom’s Stelo Achieves OTC Approval, Leading CGM Market for Non-Insulin Type 2 Diabetes Patients
CNET USA Overview Dexcom's Stelo has received FDA over-the-counter (OTC) approval, establishing it as a market leader in continuous glucose monitoring (CGM) for non-insulin users with Type 2 diabetes. The device provides real-time glucos... -
Consumer Smartwatch Technology in Health and Performance Research: Validity, Limitations, and the Challenge of Non-Invasive Glucose Sensing Highlighted
MDPI Switzerland Overview This review examines the validity, limitations, and real-world applications of consumer smartwatch technology in health and performance research, emphasizing the need for stronger validation and standardized dat... -
Medtronic Introduces Instinct Sensor, Expands MiniMed 780G System to Type 2 Diabetes with Dual FDA Clearances
Simply Wall St USA Overview Medtronic has expanded its diabetes sensor portfolio with the launch of the Instinct sensor, complementing its Simplera Sync™ and Guardian™ 4 sensors. The company also secured two key U.S. FDA regulatory miles... -
Advances and Challenges in Wearable Sensors: Non-Invasive Monitoring and AI Integration Revolutionize Health Management
ACS Publications USA Overview This mega-review explores the state-of-the-art in wearable (bio)sensors for health monitoring, emphasizing the shift towards continuous, non- or minimally invasive measurements of bodily fluids like sweat, s... -
Wireless Wearable Biosensors Advance Real-Time Health Monitoring: Capabilities and Challenges Explored
AZoLifeSciences Unknown Overview This article discusses the rapid advancements in wireless, battery-free wearable biosensors for continuous health monitoring. These devices track physiological signals and biomarkers like glucose, lactate... -
Diabeloop and ViCentra Launch Smartphone-Controlled DBLG2 System Integrated with Kaleido Patch Pump and Dexcom G7 CGM for Prescription in Germany
Press Release Hub Germany Overview Diabeloop and ViCentra have launched their DBLG2 Automated Insulin Delivery (AID) system for prescription in Germany, integrating ViCentra's Kaleido insulin patch pump with the Dexcom G7 Continuous Gluc...
